BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 6327244)

  • 1. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
    Lamberts SW; Uitterlinden P; Bons EG; Zuiderwijk JM; Verleun T; Oosterom R; Hackeng WH
    Endocrinology; 1984 Jun; 114(6):2349-53. PubMed ID: 6327244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Aminobutyric acid inhibits beta-endorphin secretion from the anterior pituitary but not the neurointermediate lobe in the rat.
    Petraglia F; Cella SG; Radice L; Genazzani AR; Müller EE
    Endocrinology; 1986 Jan; 118(1):360-6. PubMed ID: 2934244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
    Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
    Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of beta-endorphin-induced prolactin release by alpha-melanocyte-stimulating hormone and corticotropin-like intermediate lobe peptide.
    Wardlaw SL; Smeal MM; Markowitz CE
    Endocrinology; 1986 Jul; 119(1):112-8. PubMed ID: 3013583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of adrenocorticotropin/endorphin-related peptide secretion in neonatal rat pituitary cultures.
    Sato SM; Mains RE
    Endocrinology; 1986 Aug; 119(2):793-801. PubMed ID: 2426088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.
    Lamberts SW; Bons EG; Uitterlinden P; Hackeng WH
    J Endocrinol; 1983 Mar; 96(3):395-400. PubMed ID: 6300274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH, LPH, and beta-endorphin secretion from perfused isolated human pituitary tumour cells in vitro.
    Gillies G; Ratter S; Grossman A; Gaillard R; Lowry PJ; Besser GM; Rees LH
    Horm Res; 1980; 13(4-5):280-90. PubMed ID: 6268514
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoreactive beta-endorphin in the rat mammotropic transplantable tumor (MtT-F4).
    Bourassa M; Scherrer H; Pezella PD; Lis M; Chrétien M
    Cancer Res; 1978 Jun; 38(6):1568-71. PubMed ID: 206351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and dopamine independently regulate pituitary beta-endorphin release in vivo.
    Sapun-Malcolm D; Farah JM; Mueller GP
    Neuroendocrinology; 1986; 42(3):191-6. PubMed ID: 3005900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-inhibited release of prolactin and intermediate lobe-POMC-peptides: different modulation by opioids.
    Voigt KH; Frank D; Düker E; Martin R; Wuttke W
    Life Sci; 1983; 33 Suppl 1():507-10. PubMed ID: 6319905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced activity of the beta-endorphinergic system in the anterior and neurointermediate lobe of the rat pituitary after chronic treatment with ethanol liquid diet.
    Seizinger BR; Bovermann K; Höllt V; Herz A
    J Pharmacol Exp Ther; 1984 Aug; 230(2):455-61. PubMed ID: 6086890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene analog LY 117018 effects on central and peripheral beta-endorphin.
    Genazzani AR; Bernardi F; Stomati M; Rubino S; Giardina L; Luisi S; Monteleone P; Genazzani AD; Luisi M; Petraglia F
    Gynecol Endocrinol; 1999 Aug; 13(4):249-58. PubMed ID: 10533160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the beta-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary.
    Höllt V; Haarmann I; Seizinger BR; Herz A
    Endocrinology; 1982 Jun; 110(6):1885-91. PubMed ID: 6280978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of cells producing polypeptide hormones (ACTH, MSH, LPH, alpha- and beta-endorphin, GH and PRL) in the fetal porcine anterior pituitary.
    Dacheux F
    Cell Tissue Res; 1984; 235(3):615-21. PubMed ID: 6143618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-endorphin and its congeners in rat pituitary and thyroid: effects of propylthiouracil and thyroid hormone administration.
    Cheng MC; Smith AI; Funder JW
    Endocrinology; 1986 Aug; 119(2):642-7. PubMed ID: 2942390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oxytocin alone and in combination with selected hypothalamic hormones on ACTH, beta-endorphin, LH and PRL secretion by anterior pituitary cells of cyclic pigs.
    Kotwica G; Staszkiewicz J; Skowroński MT; Siawrys G; Bogacka I; Franczak A; Kurowicka B; Kraziński B; Okrasa S
    Reprod Biol; 2006 Jul; 6(2):115-31. PubMed ID: 17173093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain.
    Sweep CG; Boersma CJ; Wiegant VM
    Neuropharmacology; 1990 Jan; 29(1):61-8. PubMed ID: 1689470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.